Suppr超能文献

揭示缺陷基因的作用。

Unravelling the role of defective genes.

机构信息

Cell Biology and Gene Expression Unit, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA.

出版信息

Prog Brain Res. 2010;183:43-57. doi: 10.1016/S0079-6123(10)83003-1.

Abstract

Several genes that cause familial forms of Parkinson's disease (PD) or similar disorders have been found in recent years. The aim of this review is to cover two broad aspects of the logic of genetics. The first aspect is the recognition that PD can have a genetic basis, either for Mendelian families where genes can be identified because mutations segregate with disease or in populations where more common variants are associated with disease. There are several causal genes for both dominant and recessive forms of parkinsonism, some of which overlap with sporadic PD and some of which have more complex phenotypes. Several of the dominant loci have also been reliably identified as risk factors for sporadic PD. The second topic is how the study of multiple mutations in any given gene can help understand the role that the protein under investigation plays in PD. Examples will be given of both recessive and dominant genes for parkinsonism, showing how the analysis of multiple gene mutations can be a powerful approach for dissecting out which function(s) are important for the disease process.

摘要

近年来,已经发现了一些导致家族性帕金森病 (PD) 或类似疾病的基因。本综述的目的是涵盖遗传学逻辑的两个广泛方面。第一个方面是认识到 PD 可能具有遗传基础,无论是在可以识别基因的孟德尔家族中,因为突变与疾病分离,还是在与疾病相关的常见变体较多的人群中。有几个导致帕金森病的显性和隐性形式的因果基因,其中一些与散发性 PD 重叠,一些则具有更复杂的表型。几个显性基因座也已被可靠地确定为散发性 PD 的危险因素。第二个主题是研究给定基因中的多个突变如何帮助理解该蛋白在 PD 中所起的作用。将举例说明帕金森病的显性和隐性基因,展示分析多个基因突变如何成为剖析对疾病过程重要的功能的有力方法。

相似文献

1
Unravelling the role of defective genes.
Prog Brain Res. 2010;183:43-57. doi: 10.1016/S0079-6123(10)83003-1.
2
Clinical genetics of Parkinson's disease and related disorders.
Parkinsonism Relat Disord. 2007;13 Suppl 3:S229-32. doi: 10.1016/S1353-8020(08)70007-5.
3
Genetics and epigenetics of Parkinson's disease.
ScientificWorldJournal. 2012;2012:489830. doi: 10.1100/2012/489830. Epub 2012 May 1.
4
From genes to proteins in mendelian Parkinson's disease: an overview.
Anat Rec (Hoboken). 2009 Dec;292(12):1893-901. doi: 10.1002/ar.20968.
5
What genetics tells us about the causes and mechanisms of Parkinson's disease.
Physiol Rev. 2011 Oct;91(4):1161-218. doi: 10.1152/physrev.00022.2010.
6
Genetics of Parkinson's disease and parkinsonism.
Expert Rev Neurother. 2007 Jun;7(6):657-66. doi: 10.1586/14737175.7.6.657.
7
Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.
Parkinsonism Relat Disord. 2012 Jun;18(5):567-71. doi: 10.1016/j.parkreldis.2012.02.018. Epub 2012 Mar 24.
8
Clinical implications of gene discovery in Parkinson's disease and parkinsonism.
Mov Disord. 2010;25 Suppl 1:S15-20. doi: 10.1002/mds.22723.
9
[Familial Parkinsonism].
No To Shinkei. 2006 Aug;58(8):671-80.

引用本文的文献

1
DJ-1 in Parkinson's Disease: Clinical Insights and Therapeutic Perspectives.
J Clin Med. 2019 Sep 3;8(9):1377. doi: 10.3390/jcm8091377.
2
Rafts, Nanoparticles and Neural Disease.
Nanomaterials (Basel). 2012 Aug 6;2(3):217-250. doi: 10.3390/nano2030217.
3
Genetics of Parkinson's disease - a clinical perspective.
J Mov Disord. 2012 Oct;5(2):33-41. doi: 10.14802/jmd.12009. Epub 2012 Oct 30.
4
Physiological phenotype and vulnerability in Parkinson's disease.
Cold Spring Harb Perspect Med. 2012 Jul;2(7):a009290. doi: 10.1101/cshperspect.a009290.
5
Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.
Neuropsychopharmacology. 2012 Jan;37(1):213-46. doi: 10.1038/npp.2011.212. Epub 2011 Sep 28.

本文引用的文献

3
Mechanisms in dominant parkinsonism: The toxic triangle of LRRK2, alpha-synuclein, and tau.
Bioessays. 2010 Mar;32(3):227-235. doi: 10.1002/bies.200900163.
4
PINK1 is selectively stabilized on impaired mitochondria to activate Parkin.
PLoS Biol. 2010 Jan 26;8(1):e1000298. doi: 10.1371/journal.pbio.1000298.
6
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1.
Nat Cell Biol. 2010 Feb;12(2):119-31. doi: 10.1038/ncb2012. Epub 2010 Jan 24.
7
Clinical features of LRRK2 parkinsonism.
Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S205-8. doi: 10.1016/S1353-8020(09)70815-6.
9
The WD40 domain is required for LRRK2 neurotoxicity.
PLoS One. 2009 Dec 24;4(12):e8463. doi: 10.1371/journal.pone.0008463.
10
A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease.
Neurobiol Aging. 2011 Mar;32(3):548.e9-18. doi: 10.1016/j.neurobiolaging.2009.11.021. Epub 2009 Dec 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验